Evidence map›Paper›PMID 35957835›Full record

Observational studyFrontiers in endocrinology2022

To explore association between gamma-glutamyl transferase and type 2 diabetes using a real-world study and mendelian randomization analysis.

Yaru Bi, Shuo Yang, Yanjing Liu, Lingxia Cao, Menghan Gao, Weixia Liu, Yuting Li, Suyan Tian, Chenglin Sun

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Clinical Evidence of the Relationship Between Alanine Aminotransferase and Diabetic Kidney Disease.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yaru BiDepartment of Endocrinology and Metabolism, First Hospital of Jilin University, Changchun, China.
Shuo YangDepartment of Clinical Nutrition, First Hospital of Jilin University, Changchun, China.
Yanjing LiuDepartment of Internal Medicine, Lvyuan People's Hospital, Changchun, China.
Lingxia CaoDepartment of Endocrinology and Metabolism, First Hospital of Jilin University, Changchun, China.
Menghan GaoDepartment of Endocrinology and Metabolism, First Hospital of Jilin University, Changchun, China.
Weixia LiuDepartment of Endocrinology and Metabolism, First Hospital of Jilin University, Changchun, China.
Yuting LiDepartment of Endocrinology and Metabolism, First Hospital of Jilin University, Changchun, China.
Suyan TianDivision of Clinical Research, First Hospital of Jilin University, Changchun, China.
Chenglin SunDepartment of Endocrinology and Metabolism, First Hospital of Jilin University, Changchun, China.
First Hospital of Jilin University · CNJilin University · CNPeople 's Hospital of Jilin Province · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: The association between gamma-glutamyl transferase (GGT) and type 2 diabetes mellitus (T2DM) is controversial. In this study, we investigated the association between GGT and the risk of T2DM using real-world data, Mendelian randomization (MR) analysis, and literature mining. Methods: A cross-sectional study enrolled 3,048 participants (>40 years) from a community in Northeastern China was conducted. A generalized additive model was used to examine the relation between GGT and T2DM. A two-sample MR was performed to investigate the causal effect of GGT (61,089 individuals, mostly of European ancestry) on T2DM (29,193 cases and 182,573 controls of European ancestry). Results: GGT was related to glucose metabolism indicators, such as fasting plasma glucose and glycosylated hemoglobin ( Conclusions: Our analysis of observational study suggested that GGT, its increment, within a certain range, is indicative of the development of T2DM. However, MR analysis provided no evidence that GGT is a linear causal factor of T2DM. Further investigation is required to determine if GGT exerts a non-linear causal effect on T2DM.

Indexed as

Diabetes Mellitus, Type 2gamma-GlutamyltransferaseMendelian Randomization AnalysisCross-Sectional StudiesGlycated HemoglobinHumansgamma-GlutamyltransferaseGlycated Hemoglobinepidemiological studygamma-glutamyl transferaseMendelian randomization studysingle nucleotide polymorphismstype 2 diabetes

Identifiers

PMID35957835
PMCPMC9359111
OpenAlexW4287447663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.